nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—HTR2B—cardial valve—dilated cardiomyopathy	0.161	0.662	CbGeAlD
Methylergometrine—Acute myocardial infarction—Lisinopril—dilated cardiomyopathy	0.0551	0.158	CcSEcCtD
Methylergometrine—HTR2A—pulmonary artery—dilated cardiomyopathy	0.0348	0.143	CbGeAlD
Methylergometrine—HTR2A—sympathetic nervous system—dilated cardiomyopathy	0.0338	0.139	CbGeAlD
Methylergometrine—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.0227	0.0649	CcSEcCtD
Methylergometrine—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.0131	0.0377	CcSEcCtD
Methylergometrine—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.0123	0.0353	CcSEcCtD
Methylergometrine—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.0113	0.0322	CcSEcCtD
Methylergometrine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0104	0.0297	CcSEcCtD
Methylergometrine—Ventricular tachycardia—Lisinopril—dilated cardiomyopathy	0.0101	0.0289	CcSEcCtD
Methylergometrine—Lisuride—ADRB1—dilated cardiomyopathy	0.00895	0.519	CrCbGaD
Methylergometrine—HTR2B—heart—dilated cardiomyopathy	0.00889	0.0366	CbGeAlD
Methylergometrine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.0088	0.0252	CcSEcCtD
Methylergometrine—Bromocriptine—ADRB1—dilated cardiomyopathy	0.00829	0.481	CrCbGaD
Methylergometrine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00802	0.023	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00746	0.0214	CcSEcCtD
Methylergometrine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00628	0.018	CcSEcCtD
Methylergometrine—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00615	0.0176	CcSEcCtD
Methylergometrine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00615	0.0176	CcSEcCtD
Methylergometrine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00602	0.0173	CcSEcCtD
Methylergometrine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00582	0.0167	CcSEcCtD
Methylergometrine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00564	0.0162	CcSEcCtD
Methylergometrine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00559	0.016	CcSEcCtD
Methylergometrine—Rash—Spironolactone—dilated cardiomyopathy	0.00555	0.0159	CcSEcCtD
Methylergometrine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00554	0.0159	CcSEcCtD
Methylergometrine—Headache—Spironolactone—dilated cardiomyopathy	0.00551	0.0158	CcSEcCtD
Methylergometrine—Haematuria—Lisinopril—dilated cardiomyopathy	0.00537	0.0154	CcSEcCtD
Methylergometrine—Nausea—Spironolactone—dilated cardiomyopathy	0.00523	0.015	CcSEcCtD
Methylergometrine—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00515	0.0147	CcSEcCtD
Methylergometrine—Hallucination—Lisinopril—dilated cardiomyopathy	0.00503	0.0144	CcSEcCtD
Methylergometrine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00479	0.0137	CcSEcCtD
Methylergometrine—HTR2A—heart—dilated cardiomyopathy	0.00475	0.0195	CbGeAlD
Methylergometrine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00471	0.0135	CcSEcCtD
Methylergometrine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00469	0.0135	CcSEcCtD
Methylergometrine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00463	0.0133	CcSEcCtD
Methylergometrine—Hypotension—Furosemide—dilated cardiomyopathy	0.00447	0.0128	CcSEcCtD
Methylergometrine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.0043	0.0123	CcSEcCtD
Methylergometrine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00423	0.0121	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00391	0.0112	CcSEcCtD
Methylergometrine—Palpitations—Lisinopril—dilated cardiomyopathy	0.00389	0.0111	CcSEcCtD
Methylergometrine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00378	0.0108	CcSEcCtD
Methylergometrine—Chest pain—Lisinopril—dilated cardiomyopathy	0.00375	0.0107	CcSEcCtD
Methylergometrine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00359	0.0103	CcSEcCtD
Methylergometrine—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00351	0.01	CcSEcCtD
Methylergometrine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00347	0.00995	CcSEcCtD
Methylergometrine—Hypotension—Lisinopril—dilated cardiomyopathy	0.00336	0.00962	CcSEcCtD
Methylergometrine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00328	0.00939	CcSEcCtD
Methylergometrine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00322	0.00924	CcSEcCtD
Methylergometrine—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.0032	0.00918	CcSEcCtD
Methylergometrine—Dizziness—Furosemide—dilated cardiomyopathy	0.00317	0.00907	CcSEcCtD
Methylergometrine—Vomiting—Furosemide—dilated cardiomyopathy	0.00304	0.00872	CcSEcCtD
Methylergometrine—Rash—Furosemide—dilated cardiomyopathy	0.00302	0.00865	CcSEcCtD
Methylergometrine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00302	0.00864	CcSEcCtD
Methylergometrine—Headache—Furosemide—dilated cardiomyopathy	0.003	0.00859	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00294	0.00842	CcSEcCtD
Methylergometrine—Nausea—Furosemide—dilated cardiomyopathy	0.00284	0.00815	CcSEcCtD
Methylergometrine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00284	0.00814	CcSEcCtD
Methylergometrine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00246	0.00704	CcSEcCtD
Methylergometrine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00237	0.00681	CcSEcCtD
Methylergometrine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00228	0.00654	CcSEcCtD
Methylergometrine—Rash—Lisinopril—dilated cardiomyopathy	0.00226	0.00649	CcSEcCtD
Methylergometrine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00226	0.00648	CcSEcCtD
Methylergometrine—Headache—Lisinopril—dilated cardiomyopathy	0.00225	0.00645	CcSEcCtD
Methylergometrine—Nausea—Lisinopril—dilated cardiomyopathy	0.00213	0.00611	CcSEcCtD
Methylergometrine—HTR2A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000828	0.00212	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000817	0.00209	CbGpPWpGaD
Methylergometrine—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000802	0.00205	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000797	0.00204	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000797	0.00204	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000796	0.00204	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000795	0.00203	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000793	0.00203	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000791	0.00203	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00079	0.00202	CbGpPWpGaD
Methylergometrine—HTR2C—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000789	0.00202	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000782	0.002	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000782	0.002	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000771	0.00197	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000763	0.00195	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000763	0.00195	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000763	0.00195	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000752	0.00192	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000752	0.00192	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00075	0.00192	CbGpPWpGaD
Methylergometrine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000748	0.00192	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000747	0.00191	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000741	0.0019	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000727	0.00186	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000724	0.00185	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000724	0.00185	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00072	0.00184	CbGpPWpGaD
Methylergometrine—HTR2C—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000718	0.00184	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000718	0.00184	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00071	0.00182	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000704	0.0018	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000699	0.00179	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000687	0.00176	CbGpPWpGaD
Methylergometrine—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000685	0.00175	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000683	0.00175	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000683	0.00175	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000677	0.00173	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000676	0.00173	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000673	0.00172	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000669	0.00171	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000669	0.00171	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000652	0.00167	CbGpPWpGaD
Methylergometrine—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00065	0.00166	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000642	0.00164	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000641	0.00164	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000638	0.00163	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000635	0.00162	CbGpPWpGaD
Methylergometrine—HTR2A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000624	0.0016	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000622	0.00159	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000615	0.00157	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000613	0.00157	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000605	0.00155	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000603	0.00154	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000602	0.00154	CbGpPWpGaD
Methylergometrine—HTR2B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00059	0.00151	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000587	0.0015	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000582	0.00149	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000581	0.00149	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000581	0.00149	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000578	0.00148	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000571	0.00146	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000558	0.00143	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000557	0.00143	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000557	0.00142	CbGpPWpGaD
Methylergometrine—DRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000556	0.00142	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000553	0.00141	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000549	0.0014	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00054	0.00138	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000528	0.00135	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000525	0.00134	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000523	0.00134	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000515	0.00132	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000498	0.00127	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000488	0.00125	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000482	0.00123	CbGpPWpGaD
Methylergometrine—HTR2C—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000476	0.00122	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000469	0.0012	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000469	0.0012	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000454	0.00116	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000451	0.00116	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000449	0.00115	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000447	0.00114	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000446	0.00114	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000442	0.00113	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000442	0.00113	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000436	0.00112	CbGpPWpGaD
Methylergometrine—HTR1F—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000431	0.0011	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000428	0.00109	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000428	0.00109	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000426	0.00109	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000426	0.00109	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000426	0.00109	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000424	0.00109	CbGpPWpGaD
Methylergometrine—DRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000423	0.00108	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000422	0.00108	CbGpPWpGaD
Methylergometrine—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000413	0.00106	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000411	0.00105	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00041	0.00105	CbGpPWpGaD
Methylergometrine—HTR1E—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000407	0.00104	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000403	0.00103	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000403	0.00103	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000402	0.00103	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000402	0.00103	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000398	0.00102	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000398	0.00102	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000396	0.00101	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000392	0.001	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000387	0.000991	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000387	0.00099	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000385	0.000985	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000383	0.000981	CbGpPWpGaD
Methylergometrine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000379	0.00097	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000378	0.000968	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000378	0.000968	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000375	0.00096	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000373	0.000955	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00037	0.000946	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000363	0.00093	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000362	0.000927	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000362	0.000925	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000361	0.000923	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000352	0.0009	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000344	0.000879	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000344	0.000879	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000342	0.000875	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000341	0.000872	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00034	0.00087	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000329	0.000842	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000328	0.000841	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000328	0.000841	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000327	0.000838	CbGpPWpGaD
Methylergometrine—HTR2A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000327	0.000836	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000323	0.000826	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000319	0.000817	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000315	0.000805	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000312	0.000798	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000311	0.000795	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00031	0.000794	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000309	0.000792	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000309	0.00079	CbGpPWpGaD
Methylergometrine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000306	0.000782	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000305	0.000782	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000298	0.000763	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000298	0.000763	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000296	0.000757	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000294	0.000753	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000293	0.00075	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000291	0.000744	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000283	0.000725	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000277	0.00071	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000276	0.000706	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000272	0.000696	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000269	0.000687	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000268	0.000686	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000267	0.000684	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000266	0.00068	CbGpPWpGaD
Methylergometrine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000265	0.000679	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000264	0.000676	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000256	0.000656	CbGpPWpGaD
Methylergometrine—HTR2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000254	0.000649	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000253	0.000647	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000253	0.000646	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000252	0.000644	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000252	0.000644	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000251	0.000641	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00025	0.000641	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000242	0.00062	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000241	0.000617	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00024	0.000613	CbGpPWpGaD
Methylergometrine—DRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000239	0.000612	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000237	0.000607	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000237	0.000607	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000234	0.000598	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—AGT—dilated cardiomyopathy	0.000231	0.000592	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00023	0.00059	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000229	0.000587	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000229	0.000585	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000228	0.000585	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000227	0.000582	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000226	0.00058	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000221	0.000564	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—AGT—dilated cardiomyopathy	0.000218	0.000559	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	0.000218	0.000559	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000218	0.000557	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000217	0.000556	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000214	0.000548	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000214	0.000547	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	0.000205	0.000525	CbGpPWpGaD
Methylergometrine—HTR2C—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000205	0.000524	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000203	0.000519	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000203	0.000519	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000198	0.000508	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000195	0.000498	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000193	0.000495	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000189	0.000483	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000186	0.000477	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000186	0.000476	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000186	0.000476	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	0.000186	0.000475	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000183	0.00047	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000183	0.000468	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000182	0.000467	CbGpPWpGaD
Methylergometrine—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000178	0.000455	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000176	0.000451	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000176	0.000451	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000176	0.00045	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000173	0.000443	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000169	0.000432	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000164	0.000419	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000161	0.000413	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000161	0.000411	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00016	0.000409	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000159	0.000406	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000158	0.000404	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000156	0.000399	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000151	0.000388	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000151	0.000386	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000149	0.000381	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000148	0.000379	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000142	0.000365	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000136	0.000348	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000136	0.000347	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000134	0.000344	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000129	0.00033	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000129	0.000329	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000128	0.000328	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000127	0.000326	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000115	0.000294	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000112	0.000287	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00011	0.000283	CbGpPWpGaD
Methylergometrine—HTR1F—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00011	0.000282	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—AGT—dilated cardiomyopathy	0.00011	0.000281	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00011	0.000281	CbGpPWpGaD
Methylergometrine—HTR1E—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000104	0.000266	CbGpPWpGaD
Methylergometrine—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000103	0.000265	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	9.98e-05	0.000255	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	9.54e-05	0.000244	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—RAF1—dilated cardiomyopathy	9.45e-05	0.000242	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	8.91e-05	0.000228	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling by GPCR—EGFR—dilated cardiomyopathy	8.85e-05	0.000226	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.68e-05	0.000197	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—RAF1—dilated cardiomyopathy	7.62e-05	0.000195	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	6.62e-05	0.000169	CbGpPWpGaD
Methylergometrine—HTR2B—Signaling Pathways—EGFR—dilated cardiomyopathy	6.48e-05	0.000166	CbGpPWpGaD
Methylergometrine—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	6.11e-05	0.000156	CbGpPWpGaD
Methylergometrine—HTR2C—Signaling Pathways—EGFR—dilated cardiomyopathy	5.23e-05	0.000134	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	5.04e-05	0.000129	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	4.91e-05	0.000126	CbGpPWpGaD
Methylergometrine—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.54e-05	0.000116	CbGpPWpGaD
Methylergometrine—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	4.42e-05	0.000113	CbGpPWpGaD
